CorMedix Inc. (CRMD)

CorMedix Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	948	491	206	174	173	239
Market Cap Growth	72.24%	138.57%	18.32%	0.53%	-27.41%	27.86%
Enterprise Value	871	446	120	116	102	203
Last Close Price	13.98	8.10	3.76	4.22	4.55	7.43
Forward PE	17.26	12.27	-	-	-	-
PS Ratio	10.30	11.31	-	2662.04	907.08	997.29
PB Ratio	8.24	5.81	2.94	3.16	2.76	5.40
P/TBV Ratio	8.38	5.94	2.94	3.16	2.76	5.40
EV/Sales Ratio	10.55	10.26	-	1772.75	535.14	846.85
Debt / Equity Ratio	0.00	0.01	0.01	0.02	0.02	0.02
Asset Turnover	0.76	0.43	-	0.00	0.00	0.01
Inventory Turnover	0.81	0.66	-	-	2.03	0.85
Quick Ratio	3.84	3.05	6.67	9.32	12.26	11.14
Current Ratio	4.21	3.39	6.97	9.44	12.44	11.58
Return on Equity (ROE)	19.87%	-23.16%	-74.02%	-50.40%	-52.72%	-64.91%
Return on Assets (ROA)	8.31%	-13.91%	-42.47%	-29.23%	-31.12%	-43.19%
Return on Capital (ROIC)	10.40%	-17.92%	-48.31%	-32.01%	-33.77%	-49.38%
Earnings Yield	1.81%	-3.65%	-22.49%	-17.06%	-16.29%	-9.23%
FCF Yield	-1.44%	-10.32%	-18.80%	-14.12%	-13.04%	-9.25%
Buyback Yield / Dilution	-13.79%	-15.65%	-26.39%	-6.93%	-31.87%	-18.26%

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q